Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | PF-06755990 |
| Synonyms | |
| Therapy Description |
PF-06755990 is cancer vaccine being developed for use in combination with the antiangiogenic therapy, Sunitinib (PMID: 29508855). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| PF-06755990 | PF06755990|PF 06755990 | PF-06755990 is cancer vaccine being developed for use in combination with the antiangiogenic therapy, Sunitinib (PMID: 29508855). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|